Canaccord Genuity Group Cuts Bioceres Crop Solutions (NASDAQ:BIOX) Price Target to $2.00

Bioceres Crop Solutions (NASDAQ:BIOX) had its price objective reduced by Canaccord Genuity Group from $2.25 to $2.00 in a research note issued to investors on Friday morning,Benzinga reports. Canaccord Genuity Group currently has a hold rating on the stock.

BIOX has been the subject of a number of other reports. Wall Street Zen upgraded shares of Bioceres Crop Solutions from a “sell” rating to a “hold” rating in a research note on Saturday, November 22nd. Oppenheimer downgraded shares of Bioceres Crop Solutions from an “outperform” rating to a “market perform” rating in a research report on Wednesday, October 22nd. Lake Street Capital decreased their target price on shares of Bioceres Crop Solutions from $8.00 to $5.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research note on Monday, December 29th. One research analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $4.00.

Bioceres Crop Solutions Trading Up 3.1%

Shares of NASDAQ:BIOX opened at $1.35 on Friday. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.94 and a quick ratio of 0.64. Bioceres Crop Solutions has a 1 year low of $1.20 and a 1 year high of $7.44. The company has a market cap of $85.36 million, a P/E ratio of -1.61 and a beta of 0.47. The stock’s fifty day moving average price is $1.59 and its 200-day moving average price is $2.45.

Hedge Funds Weigh In On Bioceres Crop Solutions

A number of institutional investors have recently bought and sold shares of BIOX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Bioceres Crop Solutions by 9.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 823,916 shares of the company’s stock worth $3,761,000 after buying an additional 71,581 shares during the period. Walleye Capital LLC bought a new position in shares of Bioceres Crop Solutions during the 1st quarter valued at approximately $199,000. Avanza Fonder AB raised its stake in Bioceres Crop Solutions by 62.9% during the 2nd quarter. Avanza Fonder AB now owns 26,164 shares of the company’s stock worth $117,000 after acquiring an additional 10,099 shares during the period. PDT Partners LLC bought a new stake in Bioceres Crop Solutions during the 1st quarter worth approximately $81,000. Finally, Susquehanna International Group LLP purchased a new position in Bioceres Crop Solutions during the third quarter valued at approximately $315,000. 17.68% of the stock is owned by institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.